Draganov P, Durrence H, Cox C, Reuben A
Division of Gastroenterology, Hepatology, and Nutrition, University of Florida College of Medicine, Gainesville, USA.
Postgrad Med. 2000 Jan;107(1):189-95. doi: 10.3810/pgm.2000.01.831.
In long-term alcohol users, the syndrome of hepatotoxicity from acetaminophen taken in therapeutic or modestly excessive doses is distinctive. It is characterized by striking elevation of transaminase levels and the potential for acute liver failure with high morbidity and mortality rates. A high index of suspicion should be maintained; in any patient with evidence of acute hepatic injury, a complete history of over-the-counter drug use should be obtained and acetaminophen levels checked. If there is doubt about the dose or time of ingestion, one should err on the side of treatment with acetylcysteine, because it is both effective and safe. Therapy should be initiated as early as possible, but even late administration may be of benefit. Timely contact with a medical center that has liver transplantation capabilities should be made before encephalopathy becomes advanced. Heightened awareness of this preventable and treatable condition is needed by healthcare providers and acetaminophen users alike. Because the minimum safe dose of acetaminophen is not known in the setting of chronic alcohol use, it seems prudent in such situations to avoid acetaminophen altogether, especially during brief periods of abstinence.
在长期饮酒者中,服用治疗剂量或略超剂量对乙酰氨基酚所导致的肝毒性综合征具有独特性。其特征为转氨酶水平显著升高,且有发生急性肝衰竭的可能,发病率和死亡率较高。应保持高度怀疑;对于任何有急性肝损伤证据的患者,都应获取完整的非处方药物使用史并检查对乙酰氨基酚水平。如果对摄入剂量或时间存在疑问,应选择使用乙酰半胱氨酸进行治疗,因为它既有效又安全。治疗应尽早开始,但即使延迟给药也可能有益。在脑病进展之前,应及时联系具备肝移植能力的医疗中心。医疗服务提供者和对乙酰氨基酚使用者都需要提高对这种可预防和可治疗病症的认识。由于在慢性饮酒情况下对乙酰氨基酚的最低安全剂量尚不清楚,在这种情况下完全避免使用对乙酰氨基酚似乎是谨慎之举,尤其是在短暂戒酒期间。